17.02.2023 • NewsGenentechRochebiologics

Genentech Builds Biologics Facility in California

Genentech, the US biotech arm of Swiss pharma giant Roche, is building a new small-batch biologics manufacturing facility at its Oceanside campus in California, USA. Groundbreaking took place on Feb. 10.

The facility is scheduled to go into operation in early 2025, creating approximately 150 additional full-time jobs. Genentech said it will be the first location in its global manufacturing network that is designed specifically for the fast, efficient and sustainable commercial production of biologics for smaller patient populations, including rare diseases and personalized medicines.

The company explained that it chose Oceanside for this latest $450 million investment because of the site’s proximity to its Clinical Supply Center in South San Francisco, as well as access to world-class biotech talent.

The facility will be modeled on the Clinical Supply Center and incorporate the same technologies. Genentech said that by standardizing the design of both its California plants, it will reduce the time needed to transfer production from the clinical site to its commercial facility to just a few days, rather than the usual six to 18 months.

Author: Elaine Burridge, Freelance Journalist

Genentechs US campus in Oceanside. Source: Genentech/Roche
Genentech's US campus in Oceanside. Source: Genentech/Roche

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.